SC 13G Filing

Company

VERTEX PHARMACEUTICALS INC / MA

Filed

February 13, 2017

Accession Number

0000932471-17-002541

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →